trending Market Intelligence /marketintelligence/en/news-insights/trending/iqzoqqyvrnxakicn-4skkg2 content esgSubNav
In This List

MYM Nutraceuticals closes deal to buy medical cannabis delivery software

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


MYM Nutraceuticals closes deal to buy medical cannabis delivery software

MYM Nutraceuticals Inc. closed a deal to buy assets from Budly Software Inc. for about C$1.9 million, payable in 800,000 common shares.

The U.S.-based software company, known as the Uber for medical cannabis, developed a smartphone application that connects patients with local dispensary drivers for fast delivery and monitoring of medicinal cannabis orders.

Canada-based medicinal cannabis producer MYM had signed a letter of intent to acquire Budly on Jan. 5.

"The Budly software brings MYM one step closer to becoming a fully integrated global cannabis company," said MYM CEO Rob Gietl.